vs
艾伯维（ARGX）与RENAISSANCERE HOLDINGS LTD（RNR）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是RENAISSANCERE HOLDINGS LTD的1.1倍（$2.5B vs $2.2B），艾伯维净利率更高（35.5% vs 23.5%，领先12.0%），艾伯维同比增速更快（83.2% vs -36.8%）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
RenaissanceRe Holdings Ltd是总部位于百慕大的保险及相关商业服务提供商，核心业务覆盖再保险、常规保险两大板块，同时运营风险相关创新投资业务，为全球客户提供专业的风险对冲与保险解决方案。
ARGX vs RNR — 直观对比
营收规模更大
ARGX
是对方的1.1倍
$2.2B
营收增速更快
ARGX
高出120.0%
-36.8%
净利率更高
ARGX
高出12.0%
23.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $2.2B |
| 净利润 | $877.2M | $515.8M |
| 毛利率 | 89.5% | — |
| 营业利润率 | 28.9% | — |
| 净利率 | 35.5% | 23.5% |
| 营收同比 | 83.2% | -36.8% |
| 净利润同比 | 1.3% | 72.6% |
| 每股收益（稀释后） | $13.25 | $6.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXRNR
| Q1 26 | — | $2.2B | ||
| Q4 25 | $2.5B | $3.0B | ||
| Q3 25 | — | $3.2B | ||
| Q2 25 | $1.8B | $3.2B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | $901.9M | $2.8B |
净利润ARGXRNR
| Q1 26 | — | $515.8M | ||
| Q4 25 | $877.2M | $760.5M | ||
| Q3 25 | — | $916.5M | ||
| Q2 25 | $414.8M | $835.4M | ||
| Q1 25 | — | $170.0M | ||
| Q4 24 | $865.6M | $-189.7M | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $-32.5M | $503.9M |
毛利率ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 89.4% | — |
营业利润率ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 28.9% | 42.5% | ||
| Q3 25 | — | 46.3% | ||
| Q2 25 | 19.2% | 41.8% | ||
| Q1 25 | — | -2.0% | ||
| Q4 24 | 8.7% | -3.6% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | -15.4% | 25.0% |
净利率ARGXRNR
| Q1 26 | — | 23.5% | ||
| Q4 25 | 35.5% | 25.6% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | 23.4% | 26.1% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | 64.1% | -8.3% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | -3.6% | 17.8% |
每股收益（稀释后）ARGXRNR
| Q1 26 | — | $6.57 | ||
| Q4 25 | $13.25 | $16.16 | ||
| Q3 25 | — | $19.40 | ||
| Q2 25 | $6.32 | $17.20 | ||
| Q1 25 | — | $3.27 | ||
| Q4 24 | $13.33 | $-3.76 | ||
| Q3 24 | — | $22.62 | ||
| Q2 24 | $-0.55 | $9.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $1.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3B | $4.3B |
| 总资产 | $8.7B | $53.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARGXRNR
| Q1 26 | — | $1.6B | ||
| Q4 25 | $3.5B | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $1.4B | $1.6B |
总债务ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | $11.0M | $2.0B |
股东权益ARGXRNR
| Q1 26 | — | $4.3B | ||
| Q4 25 | $7.3B | $11.6B | ||
| Q3 25 | — | $11.5B | ||
| Q2 25 | $6.1B | $10.8B | ||
| Q1 25 | — | $10.3B | ||
| Q4 24 | $5.5B | $10.6B | ||
| Q3 24 | — | $11.2B | ||
| Q2 24 | $4.3B | $10.2B |
总资产ARGXRNR
| Q1 26 | — | $53.7B | ||
| Q4 25 | $8.7B | $53.8B | ||
| Q3 25 | — | $54.5B | ||
| Q2 25 | $7.2B | $54.7B | ||
| Q1 25 | — | $53.6B | ||
| Q4 24 | $6.2B | $50.7B | ||
| Q3 24 | — | $52.8B | ||
| Q2 24 | $4.8B | $51.6B |
负债/权益比ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | 0.00× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | — |
| 自由现金流经营现金流 - 资本支出 | $322.4M | — |
| 自由现金流率自由现金流/营收 | 13.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | — |
8季度趋势，按日历期对齐
经营现金流ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $483.0M | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $361.8M | $1.5B | ||
| Q1 25 | — | $157.8M | ||
| Q4 24 | $41.9M | $778.9M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $-124.7M | $1.2B |
自由现金流ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $356.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — |
自由现金流率ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — |
资本支出强度ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — |
现金转化率ARGXRNR
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 0.64× | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | 0.87× | 1.76× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | — | 2.41× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
